ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PRSM Blue Prism Group Plc

1,274.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Blue Prism Group Plc LSE:PRSM London Ordinary Share GB00BYQ0HV16 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,274.00 1,274.00 1,275.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Blue Prism Share Discussion Threads

Showing 7176 to 7197 of 8350 messages
Chat Pages: Latest  298  297  296  295  294  293  292  291  290  289  288  287  Older
DateSubjectAuthorDiscuss
03/5/2021
19:33
A lot could depend on the guidance of course and considering RPA is obsolete and outdated to many market participants, Blue Prism has got a lot to prove. Even with a sales guidance towards annual sales $250 million USD for 2021, the company would have to back that up with at least $115-$117 million for the 6 months and if those numbers are not there, this one will be sold off to 9 Sterlings for a share. So a lot of pressure there. It is certainly an interesting price point if you fully consider the potential down side.
danschmeidler
03/5/2021
19:28
The company would have to report 6 months sales of minimum USD $112 million. The company never broke the $100 million USD 6 months sales figure. so this could be a challenge and market is very nervous as it appears anything below $100 million USD in 6 months worth of sales will be seen as a total disaster. So market is setting stock up for potential failure. 6 months sales of $117 million would probably satisfy market at this point to just hold 12 Sterling.
danschmeidler
03/5/2021
06:25
It’s worth more on a market valuation basis, while on the basis of its stock price it’s worth about the same or less since heavy dilution results in a smaller percentage ownership of the company for its stock. It’s either a good buying opportunity or just simply a good entry point for new investors. Not sure how long term investors are reacting right now but looks like it trades more like a day trading stock.
danschmeidler
01/5/2021
01:32
Is PRSM now worth less than it was 3 yrs ago?????
hatfullofsky
30/4/2021
16:06
Lsoc85, sure, pick only what you want to make an argument! This new report has only been here for a few weeks which is why it was mentioned. Read the report, they are no longer 3rd or even in a leader and have clearly moved from 3rd to 12th on strategy. Likewise you need to stop comparing valuation on what is not like for like. Growth, revenue and market as All very different to uipath. BP has lost virtually all first mover advantage you were all so proud of but as I said, if moving to NASDAQ gives investors what they want just do it.
dannyboylife
29/4/2021
21:55
Danny, the messenger normally delivers the message and that's the end of it. You've been banging the drum of Forrester every time anyone says anything.

And ultimately, the graph still shows PRSM as having the third best current offering. Globally. PATH is currently valued at c.£30B. Do you think Forrester would think £30B vs £1.3B is a fair valuation? I would say that Forrester's graph would not suggest so.

lsoc85
29/4/2021
15:40
Back in today, 1220
hatfullofsky
29/4/2021
14:19
Lsoc85, PRSM themselves talk up Forrester positioning from RPA waves to support their lead / first mover. How times change. This new wave is just out. Stop shooting the messenger.
dannyboylife
29/4/2021
13:53
BRSM FAT CAT CITY BoD are cluless
dg1966
28/4/2021
20:56
Good grief, Danny. You mention Forrester in every single post you make. Like a chuffing broken record. If you're that enamoured with Forrester, go and marry them.
lsoc85
28/4/2021
20:10
I feel we’ve had this dance before. It’s software, as a first mover you have to get into as many companies as you can, even if that means initial high sales costs, then watch the recurring revenue build and the licence fees grow.
bluepeter1
28/4/2021
19:19
BluePeter: but those sales came with a ton of sales and marketing expense and with less competition v today. Most other competing "Automation" companies have many more technologies whereas BP mostly partners. Forrester lowering BP score significantly this time around is based on many of these aspects.
dannyboylife
28/4/2021
18:42
The chat on here has not moved on for years. Meanwhile BP’s revenue continues to grow, £10m revenue and 153 customers in 2016 compared to £141m and 2031 customers in 2020...not bad growth really.
bluepeter1
27/4/2021
13:59
If you look at the software companies that now have, and target RPA for the enterprise, with intelligent automation combined with RPA capabilities, you will see Appian, SAP, Service Now, Kofax, Pega, IBM, Nice systems and many others. BluePrism seems to have lost a lot of its lead, even ignoring Uipath. Compared with the last Forrester wave, according to the 2021 graph, they are now not even in the "leader" position and what should be more concerning, PRSM have been pushed much further left on the weaker - stronger strategy line. Moving to Nasdaq cannot hurt.
dannyboylife
27/4/2021
08:33
From BP homepage :
"Blue Prism is the global leader in intelligent automation for the enterprise",

they are valued at £1,22 bn, compared to UIpath valuation at apr. £ 30,2 bn,

(I guess "for the enterprise" is the key word here).

I hope the BoD is seriously considering Nasdaq these days

gundersone
22/4/2021
16:39
Glad the witch has bought in to PATH, although she's probably bought them in her SPACE Fund as she has just about every other vertical in it . nit so sure they are all going to the "Stratospheeeeeeeerrrrrreeeeeee"

UIPATH has had limited impact on PRSM . BoD need to ask themselves why ????? yesterdays child maybe

dg1966
22/4/2021
09:38
ARK funds Cathie Wood loading up heavily on UiPath:

hxxps://markets.businessinsider.com/news/stocks/cathie-wood-loads-up-heavily-on-debutant-uipath-trims-tesla-1030331328

mccore
21/4/2021
23:39
The report still names PRSM as a strong performer with 3rd best current offering globally. The board will likely take feedback on the need to improve on strategy. But it doesn't appear to be as brutal as you're making it out to be? It still appears that Forresters have a lot of love for the company. Or am I missing some damning excerpt?
lsoc85
21/4/2021
22:05
Investors like growth and in this very crowded market, PATH has gone in a different direction with RPA. PRSM stayed true to its original message but this is now more out of favor v the bot for everyone which MS and UIPath are chasing. Thus I think, for investors anyway, UIpath have a massive advantage over PRSM. Forrester definitely did not do PRSM an favors in the last report which is more damaging given they were high favorite for a while.
dannyboylife
21/4/2021
21:21
Whatever market they're chasing, a US listing is absolutely essential. And the sooner the better; the board must strike while the iron's hot.

If PRSM have an edge over PATH in something, that is music to my ears. I assume that is what you are saying? Please correct me if not.

PRSM mentioned as a competitor of UiPath in the WSJ in the last hour:

lsoc85
21/4/2021
21:08
Are you saying PRSM should now chase the PATH market of a bot for everyone and like UIpath, go head to head with MS Power Automate Desktop too (post MS softomotive acquisition)? I hear that PRSM RPA is not the same and is an enterprise (large accounts) grade digital workforce. Do the math on PATH average license revenue per customer (8000 customers)and massive community of developers. Not the same space at all. Forrester has redefined RPA, scoring UIpath high and pushed back on PRSM early wave lead as perhaps confirmation of that too.
dannyboylife
21/4/2021
20:50
UiPath floated at around 50 times revenue.
PRSM currently valued at 8 times revenue.

UiPath looks cheap... compared to the likes of Snowflake (at 70+ times revenue) etc.

So, yeah... Lol!
The "mentality" for these stocks is just not in UK Markets, that's the reality as far as I can see. And Vaccitech recognise this too, apparently.

What's that "strategist" we employed a few months ago been doing?

sogoesit
Chat Pages: Latest  298  297  296  295  294  293  292  291  290  289  288  287  Older

Your Recent History

Delayed Upgrade Clock